SYRA HEALTH CORP. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $2M | ↓-13.6% | — | — | — |
| 2025-09-30 | $2M | ↓-25.1% | $-226K | ↑+45.9% | -13.8% |
| 2025-06-30 | $2M | ↓-1.2% | $-64K | ↑+95.4% | -3.2% |
| 2025-03-31 | $2M | ↑+6.0% | $-472K | ↑+67.4% | -25.5% |
| 2024-12-31 | $2M | ↑+13.6% | — | — | — |
| 2024-09-30 | $2M | ↑+42.5% | $-418K | ↓-17.8% | -19.0% |
| 2024-06-30 | $2M | ↑+101.1% | $-1M | ↓-73.2% | -70.6% |
| 2024-03-31 | $2M | ↑+47.5% | $-1M | ↓-84.1% | -82.4% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 14 quarters
margin trajectory tells the operating-leverage storyGo deeper
SYRA Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeySYRA Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics